Clinical Trials Directory

Trials / Unknown

UnknownNCT05856461

Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension

Pulmonary Artery Denervation+ Atrial Fibrillation Ablation vs Atrial Fibrillation Ablation Only in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
Meshalkin Research Institute of Pathology of Circulation · Network
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of the study is to compare efficacy and safety of the pulmonary artery denervation procedure combined with atrial fibrillation ablation versus atrial fibrillation ablation alone in patients with paroxysmal and persistent atrial fibrillation and group 2 of the pulmonary hypertension

Conditions

Interventions

TypeNameDescription
PROCEDUREPulmonary vein isolationCircumferential pulmonary vein isolation procedure using 3D navigation systems with entrance and exit block verification
PROCEDURESham pulmonary artery denervationSham pulmonary artery denervation procedure includes 3D reconstruction of the right ventricular outflow tract, main, left and right pulmonary arteries with creation of the false ablation points. No true ablation lesions will be performed in the pulmonary artery
PROCEDUREPulmonary artery denervationPulmonary artery denervation procedure includes 3D reconstruction of the right ventricular outflow tract, main, left and right pulmonary arteries and 3 circles of ablation lesions (bifurcation of the main pulmonary artery, left and right pulmonary arteries)

Timeline

Start date
2023-05-22
Primary completion
2024-12-29
Completion
2025-02-22
First posted
2023-05-12
Last updated
2023-05-25

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05856461. Inclusion in this directory is not an endorsement.